DEF 14AThe Ballot
Keros Therapeutics, Inc. files DEF 14A
Filed Apr 17, 2024 · 2y ago · Accession 0001104659-24-048301
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Keros Therapeutics, Inc.
- Ticker
- KROS
- CIK
- 1664710
- Form type
- DEF 14A
- Filing date
- Apr 17, 2024
- Report date
- May 30, 2024
- Document
- tm242787d6_def14a.htm
- Size
- 3.9 MB